12:00 AM
 | 
Jan 16, 2001
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AeroDose albuterol: Began Phase II testing

AeroGen Inc. (AEGN), Sunnyvale, Calif.
Product: AeroDose albuterol
Business: Drug delivery
Therapeutic category: Receptor antagonist
Target:...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >